SVB Wealth LLC Sells 2,635 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

SVB Wealth LLC decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 10.0% during the 4th quarter, Holdings Channel reports. The firm owned 23,751 shares of the financial services provider’s stock after selling 2,635 shares during the quarter. SVB Wealth LLC’s holdings in iShares Biotechnology ETF were worth $3,227,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in IBB. Moneta Group Investment Advisors LLC boosted its position in shares of iShares Biotechnology ETF by 131,598.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 4,469,845 shares of the financial services provider’s stock valued at $586,846,000 after purchasing an additional 4,466,451 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in iShares Biotechnology ETF by 159.9% in the first quarter. JPMorgan Chase & Co. now owns 1,966,359 shares of the financial services provider’s stock worth $253,975,000 after acquiring an additional 1,209,700 shares in the last quarter. International Assets Investment Management LLC bought a new position in iShares Biotechnology ETF in the fourth quarter worth approximately $76,425,000. Goldman Sachs Group Inc. boosted its holdings in iShares Biotechnology ETF by 49.9% in the first quarter. Goldman Sachs Group Inc. now owns 1,568,159 shares of the financial services provider’s stock worth $204,332,000 after acquiring an additional 521,820 shares in the last quarter. Finally, Itau Unibanco Holding S.A. bought a new position in iShares Biotechnology ETF in the third quarter worth approximately $48,242,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.9 %

Shares of NASDAQ:IBB opened at $125.89 on Thursday. The business’s 50 day simple moving average is $135.48 and its two-hundred day simple moving average is $129.55. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $141.16.

iShares Biotechnology ETF Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a $0.126 dividend. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a yield of 0.40%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.